Liverpool ChiroChem(LCC) is an international, chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs through expanding access to 3D chemical space. LCC has developed a suite of synthetic methodologies that have been used to produce thousands of novel, multifunctional, diverse, highly developable 3D fragments/scaffolds/BB’s. These have been produced to support NCE discovery & development within their 4 product pillars: scaffolds for DEL; enantiopair fragments; linkers for heterobifunctionals and their 3Discovery Virtual Library for screening. With the chiral market of the pharmaceutical industry moving towards enantiopure drugs, LCC have invested heavily to become an industry leader in providing absolute stereochemical determination and quantification of enantiomeric excess measurements with more than 1500 homochiral scaffolds in-stock. LCC are also there to support your hit-optimisation with access to their Parallel Synthesis Lab, nearest neighbour analogues and a follow-on FTE service.